AJP - Lung Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Lung Cell Mol Physiol 269: L151-L157, 1995;
1040-0605/95 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cohen, P.
Right arrow Articles by Grunstein, M. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cohen, P.
Right arrow Articles by Grunstein, M. M.

AJP - Lung Cellular and Molecular Physiology, Vol 269, Issue 2 151-L157, Copyright © 1995 by American Physiological Society


ARTICLES

Leukotriene D4 facilitates airway smooth muscle cell proliferation via modulation of the IGF axis

P. Cohen, J. P. Noveral, A. Bhala, S. E. Nunn, D. J. Herrick and M. M. Grunstein
Division of Endocrinology, Joseph Stokes, Jr., Research Institute, Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine 19104, USA.

The insulin-like growth factor (IGF) axis is involved in regulating proliferation in a variety of cell types, including airway smooth muscle. Because airway hyperplasia is a characteristic feature of asthma and other lung diseases, we examined the interaction of the potent proinflammatory eicosanoid leukotriene D4 (LTD4) with the IGF axis in regulating airway smooth muscle cell mitogenesis. In cultured rabbit airway smooth muscle cells, IGF-I but not LTD4 was mitogenic at submaximal concentrations. The combination of the two agents exerted a significant synergistic effect on airway smooth muscle cell mitogenesis. Analysis of airway smooth muscle cell conditioned medium by Western ligand blotting demonstrated a marked LTD4-induced reduction in the levels of the predominant IGF binding protein IGFBP-2, which is elaborated into the conditioned medium. The latter effect on IGFBP-2 release was not associated with a reduction in IGFBP-2 mRNA levels; however, LTD4-treated airway smooth muscle conditioned medium demonstrated the presence of a lower molecular weight form of IGFBP-2 by cross-linking to IGFs and specific proteolysis of radiolabeled IGFBP-2. IGFBP-2 was also noted to be associated with airway smooth muscle cell membranes, where it was protected from LTD4-induced proteolysis. Finally, exogenous administration of IGFBP-2 was found to inhibit the promitogenic effect of IGF-I in a dose-dependent manner.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. P. Vieira, V. F. de Andrade, A. C. S. Duarte, A. B. G. dos Santos, T. Mauad, M. A. Martins, M. Dolhnikoff, and C. R. F. Carvalho
Aerobic conditioning and allergic pulmonary inflammation in mice. II. Effects on lung vascular and parenchymal inflammation and remodeling
Am J Physiol Lung Cell Mol Physiol, October 1, 2008; 295(4): L670 - L679.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
R. Leigh, D. Vethanayagam, M. Yoshida, R. M. Watson, T. Rerecich, M. D. Inman, and P. M. O'Byrne
Effects of Montelukast and Budesonide on Airway Responses and Airway Inflammation in Asthma
Am. J. Respir. Crit. Care Med., November 1, 2002; 166(9): 1212 - 1217.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
B. Knorr, L. M. Franchi, H. Bisgaard, J. H. Vermeulen, P. LeSouef, N. Santanello, T. M. Michele, T. F. Reiss, H. H. Nguyen, and D. L. Bratton
Montelukast, a Leukotriene Receptor Antagonist, for the Treatment of Persistent Asthma in Children Aged 2 to 5 Years
Pediatrics, September 1, 2001; 108(3): e48 - 48.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
H. Bisgaard
Leukotriene Modifiers in Pediatric Asthma Management
Pediatrics, February 1, 2001; 107(2): 381 - 390.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
F. TSANG and W. S. FRED WONG
Inhibitors of Tyrosine Kinase Signaling Cascade Attenuated Antigen Challenge of Guinea-Pig Airways In Vitro
Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 126 - 133.
[Abstract] [Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
J. BOUSQUET, P. K. JEFFERY, W. W. BUSSE, M. JOHNSON, and A. M. VIGNOLA
Asthma . From Bronchoconstriction to Airways Inflammation and Remodeling
Am. J. Respir. Crit. Care Med., May 1, 2000; 161(5): 1720 - 1745.
[Full Text]


Home page
Am. J. Respir. Crit. Care Med.Home page
E. PALMANS, J. C. KIPS, and R. A. PAUWELS
Prolonged Allergen Exposure Induces Structural Airway Changes in Sensitized Rats
Am. J. Respir. Crit. Care Med., February 1, 2000; 161(2): 627 - 635.
[Abstract] [Full Text]


Home page
ThoraxHome page
K F Chung and P J Barnes
Cytokines in asthma
Thorax, September 1, 1999; 54(9): 825 - 857.
[Full Text]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. Rajah, R. V. Nachajon, M. H. Collins, H. Hakonarson, M. M. Grunstein, and P. Cohen
Elevated Levels of the IGF-Binding Protein Protease MMP-1 in Asthmatic Airway Smooth Muscle
Am. J. Respir. Cell Mol. Biol., February 1, 1999; 20(2): 199 - 208.
[Abstract] [Full Text]


Home page
NEJMHome page
J. M. Drazen, E. Israel, and P. M. O'Byrne
Treatment of Asthma with Drugs Modifying the Leukotriene Pathway
N. Engl. J. Med., January 21, 1999; 340(3): 197 - 206.
[Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
P. J. Barnes, K. F. Chung, and C. P. Page
Inflammatory Mediators of Asthma: An Update
Pharmacol. Rev., December 1, 1998; 50(4): 515 - 596.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. A. Panettieri Jr., E. M. L. Tan, V. Ciocca, M. A. Luttmann, T. B. Leonard, and D. W. P. Hay
Effects of LTD4 on Human Airway Smooth Muscle Cell Proliferation, Matrix Expression, and Contraction In Vitro: Differential Sensitivity to Cysteinyl Leukotriene Receptor Antagonists
Am. J. Respir. Cell Mol. Biol., September 1, 1998; 19(3): 453 - 461.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online